Enhancement of 5-fluorouracil efficacy on high COX-2 expressing HCA-7 cells by low dose indomethacin and NS-398 but not on low COX-2 expressing HT-29 cells

Andrea Réti, G. Barna, Éva Pap, Vilmos Adleff, Viktor L. Komlósi, A. Jeney, Judit Kralovánszky, Barna Budai

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The antiproliferative effect of 5-fluorouracil (5-FU) in the presence of low dose non-steroidal anti-inflammatory drugs (NSAIDs) on high cyclooxygenase-2 (COX-2)-expressing HCA-7 and low COX-2-expressing HT-29 colon carcinoma cell lines was investigated. Pharmacogenetic parameters were studied to characterize the 5-FU sensitivity of the two cell lines. Thymidylate synthase (TS) and methylenetetrahydrofolate reductase (MTHFR) polymorphisms were determined by PCR analysis. Cell proliferation was measured by SRB assay, cell cycle distribution and apoptosis by FACS analysis. Cyclooxygenase expression was detected by Western blot and also by fluorescence microscopy. Prostaglandin E2 (PGE2) levels were investigated with ELISA kit. The HT-29 cell line was found to be homozygous for TS 2R and 1494ins6 and T homozygous for MTHFR 677 polymorphisms predicting high 5-FU sensitivity (IC50: 10 μM). TS 3R homozygosity, TS 1496del6 and MTHFR 677CT heterozygosity may explain the modest 5-FU sensitivity (IC50: 1.1 mM) of the HCA-7 cell line. Indomethacin and NS-398 (10 μM and 1.77 μM, respectively) reduced the PGE2 level in HCA-7 cells (>90%). Low concentrations of NSAIDs without antiproliferative potency increased the S-phase arrest and enhanced the cytotoxic action of 5-FU only in HCA-7 cells after 48-hours treatment. The presented data suggested that the enhancement of 5-FU cytotoxicity by indomethacin or NS-398 applied in low dose is related to the potency of NSAIDs to modulate the cell-cycle distribution and the apoptosis; however, it seems that this effect might be dependent on cell phenotype, namely on the COX-2 expression.

Original languageEnglish
Pages (from-to)335-344
Number of pages10
JournalPathology and Oncology Research
Volume15
Issue number3
DOIs
Publication statusPublished - Sep 2009

Fingerprint

HT29 Cells
Cyclooxygenase 2
Indomethacin
Fluorouracil
Thymidylate Synthase
Methylenetetrahydrofolate Reductase (NADPH2)
Cell Line
Anti-Inflammatory Agents
Dinoprostone
Inhibitory Concentration 50
Cell Cycle
Pharmaceutical Preparations
Apoptosis
Pharmacogenetics
Prostaglandin-Endoperoxide Synthases
S Phase
Fluorescence Microscopy
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
Colon
Western Blotting

Keywords

  • 5-fluorouracil
  • Cell cycle phase
  • COX-2
  • HT-29 and HCA-7 cells
  • Indomethacin
  • NS-398
  • PGE

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Pathology and Forensic Medicine

Cite this

Enhancement of 5-fluorouracil efficacy on high COX-2 expressing HCA-7 cells by low dose indomethacin and NS-398 but not on low COX-2 expressing HT-29 cells. / Réti, Andrea; Barna, G.; Pap, Éva; Adleff, Vilmos; L. Komlósi, Viktor; Jeney, A.; Kralovánszky, Judit; Budai, Barna.

In: Pathology and Oncology Research, Vol. 15, No. 3, 09.2009, p. 335-344.

Research output: Contribution to journalArticle

Réti, Andrea ; Barna, G. ; Pap, Éva ; Adleff, Vilmos ; L. Komlósi, Viktor ; Jeney, A. ; Kralovánszky, Judit ; Budai, Barna. / Enhancement of 5-fluorouracil efficacy on high COX-2 expressing HCA-7 cells by low dose indomethacin and NS-398 but not on low COX-2 expressing HT-29 cells. In: Pathology and Oncology Research. 2009 ; Vol. 15, No. 3. pp. 335-344.
@article{14b9b5102551449db7447d2219a631b7,
title = "Enhancement of 5-fluorouracil efficacy on high COX-2 expressing HCA-7 cells by low dose indomethacin and NS-398 but not on low COX-2 expressing HT-29 cells",
abstract = "The antiproliferative effect of 5-fluorouracil (5-FU) in the presence of low dose non-steroidal anti-inflammatory drugs (NSAIDs) on high cyclooxygenase-2 (COX-2)-expressing HCA-7 and low COX-2-expressing HT-29 colon carcinoma cell lines was investigated. Pharmacogenetic parameters were studied to characterize the 5-FU sensitivity of the two cell lines. Thymidylate synthase (TS) and methylenetetrahydrofolate reductase (MTHFR) polymorphisms were determined by PCR analysis. Cell proliferation was measured by SRB assay, cell cycle distribution and apoptosis by FACS analysis. Cyclooxygenase expression was detected by Western blot and also by fluorescence microscopy. Prostaglandin E2 (PGE2) levels were investigated with ELISA kit. The HT-29 cell line was found to be homozygous for TS 2R and 1494ins6 and T homozygous for MTHFR 677 polymorphisms predicting high 5-FU sensitivity (IC50: 10 μM). TS 3R homozygosity, TS 1496del6 and MTHFR 677CT heterozygosity may explain the modest 5-FU sensitivity (IC50: 1.1 mM) of the HCA-7 cell line. Indomethacin and NS-398 (10 μM and 1.77 μM, respectively) reduced the PGE2 level in HCA-7 cells (>90{\%}). Low concentrations of NSAIDs without antiproliferative potency increased the S-phase arrest and enhanced the cytotoxic action of 5-FU only in HCA-7 cells after 48-hours treatment. The presented data suggested that the enhancement of 5-FU cytotoxicity by indomethacin or NS-398 applied in low dose is related to the potency of NSAIDs to modulate the cell-cycle distribution and the apoptosis; however, it seems that this effect might be dependent on cell phenotype, namely on the COX-2 expression.",
keywords = "5-fluorouracil, Cell cycle phase, COX-2, HT-29 and HCA-7 cells, Indomethacin, NS-398, PGE",
author = "Andrea R{\'e}ti and G. Barna and {\'E}va Pap and Vilmos Adleff and {L. Koml{\'o}si}, Viktor and A. Jeney and Judit Kralov{\'a}nszky and Barna Budai",
year = "2009",
month = "9",
doi = "10.1007/s12253-008-9126-9",
language = "English",
volume = "15",
pages = "335--344",
journal = "Pathology and Oncology Research",
issn = "1219-4956",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - Enhancement of 5-fluorouracil efficacy on high COX-2 expressing HCA-7 cells by low dose indomethacin and NS-398 but not on low COX-2 expressing HT-29 cells

AU - Réti, Andrea

AU - Barna, G.

AU - Pap, Éva

AU - Adleff, Vilmos

AU - L. Komlósi, Viktor

AU - Jeney, A.

AU - Kralovánszky, Judit

AU - Budai, Barna

PY - 2009/9

Y1 - 2009/9

N2 - The antiproliferative effect of 5-fluorouracil (5-FU) in the presence of low dose non-steroidal anti-inflammatory drugs (NSAIDs) on high cyclooxygenase-2 (COX-2)-expressing HCA-7 and low COX-2-expressing HT-29 colon carcinoma cell lines was investigated. Pharmacogenetic parameters were studied to characterize the 5-FU sensitivity of the two cell lines. Thymidylate synthase (TS) and methylenetetrahydrofolate reductase (MTHFR) polymorphisms were determined by PCR analysis. Cell proliferation was measured by SRB assay, cell cycle distribution and apoptosis by FACS analysis. Cyclooxygenase expression was detected by Western blot and also by fluorescence microscopy. Prostaglandin E2 (PGE2) levels were investigated with ELISA kit. The HT-29 cell line was found to be homozygous for TS 2R and 1494ins6 and T homozygous for MTHFR 677 polymorphisms predicting high 5-FU sensitivity (IC50: 10 μM). TS 3R homozygosity, TS 1496del6 and MTHFR 677CT heterozygosity may explain the modest 5-FU sensitivity (IC50: 1.1 mM) of the HCA-7 cell line. Indomethacin and NS-398 (10 μM and 1.77 μM, respectively) reduced the PGE2 level in HCA-7 cells (>90%). Low concentrations of NSAIDs without antiproliferative potency increased the S-phase arrest and enhanced the cytotoxic action of 5-FU only in HCA-7 cells after 48-hours treatment. The presented data suggested that the enhancement of 5-FU cytotoxicity by indomethacin or NS-398 applied in low dose is related to the potency of NSAIDs to modulate the cell-cycle distribution and the apoptosis; however, it seems that this effect might be dependent on cell phenotype, namely on the COX-2 expression.

AB - The antiproliferative effect of 5-fluorouracil (5-FU) in the presence of low dose non-steroidal anti-inflammatory drugs (NSAIDs) on high cyclooxygenase-2 (COX-2)-expressing HCA-7 and low COX-2-expressing HT-29 colon carcinoma cell lines was investigated. Pharmacogenetic parameters were studied to characterize the 5-FU sensitivity of the two cell lines. Thymidylate synthase (TS) and methylenetetrahydrofolate reductase (MTHFR) polymorphisms were determined by PCR analysis. Cell proliferation was measured by SRB assay, cell cycle distribution and apoptosis by FACS analysis. Cyclooxygenase expression was detected by Western blot and also by fluorescence microscopy. Prostaglandin E2 (PGE2) levels were investigated with ELISA kit. The HT-29 cell line was found to be homozygous for TS 2R and 1494ins6 and T homozygous for MTHFR 677 polymorphisms predicting high 5-FU sensitivity (IC50: 10 μM). TS 3R homozygosity, TS 1496del6 and MTHFR 677CT heterozygosity may explain the modest 5-FU sensitivity (IC50: 1.1 mM) of the HCA-7 cell line. Indomethacin and NS-398 (10 μM and 1.77 μM, respectively) reduced the PGE2 level in HCA-7 cells (>90%). Low concentrations of NSAIDs without antiproliferative potency increased the S-phase arrest and enhanced the cytotoxic action of 5-FU only in HCA-7 cells after 48-hours treatment. The presented data suggested that the enhancement of 5-FU cytotoxicity by indomethacin or NS-398 applied in low dose is related to the potency of NSAIDs to modulate the cell-cycle distribution and the apoptosis; however, it seems that this effect might be dependent on cell phenotype, namely on the COX-2 expression.

KW - 5-fluorouracil

KW - Cell cycle phase

KW - COX-2

KW - HT-29 and HCA-7 cells

KW - Indomethacin

KW - NS-398

KW - PGE

UR - http://www.scopus.com/inward/record.url?scp=73449119600&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73449119600&partnerID=8YFLogxK

U2 - 10.1007/s12253-008-9126-9

DO - 10.1007/s12253-008-9126-9

M3 - Article

C2 - 19048402

AN - SCOPUS:73449119600

VL - 15

SP - 335

EP - 344

JO - Pathology and Oncology Research

JF - Pathology and Oncology Research

SN - 1219-4956

IS - 3

ER -